NCT03922555 2025-12-18
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Massachusetts General Hospital
Phase 1 Recruiting
Clinical Trials
1 trialsRecruiting × Central Nervous System Neoplasms × decitabine and cedazuridine drug combination × Clear all